The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Multi-Targeted Natural Products Evaluation Based on Biological Activity Prediction with PASS
Abstract
Natural products found a wide use in folk medicine. Presently, when routine development of new drugs faced a considerable challenge, they become an inspiration and valuable source in drugs discovery. Rather complex and diverse chemical structures of natural compounds provide a basis for modulation of different biological targets. Natural compounds exhibit a multitargeted action that may lead to additive/synergistic or antagonistic effects. Rational design of more safe and potent pharmaceuticals requires an estimation of probable multiple actions of natural products. Our software PASS can perform such estimation. It predicts with reasonable accuracy over 3500 pharmacotherapeutic effects, mechanisms of action, interaction with the metabolic system, and specific toxicity for drug-like molecules on the basis of their structural formulae. We analyzed PASS predictions utilizing PharmaExpert, which performs selection of compounds with multiple mechanisms of action, analysis of activity-activity relationships and drug-drug interactions. The paper describes an application of PASS and PharmaExpert to the evaluation of biological activity of natural compounds including marine sponge alkaloids, triterpenoids of lupane group, and their derivatives. Proposed computer-aided methods can generate combinatorial libraries of macrolides. They help to select the most promising pharmaceutical leads with the required properties. Case study, based on the analysis of biological activity spectra predicted for St John's Wort constituents, clearly demonstrates capabilities of computational methods in the evaluation of multitargeted actions, additive/synergistic and/or antagonistic effects of natural products.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This often generates beneficial therapeutic activities,102 due to additive or synergistic pharmacological effects.103”
From QSAR without borders (2020) · cites this paper as [103]
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Handbook of Molecular Descriptors
Todeschini, R., & Consonni, V. (2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613106 · Cited by 4,107
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,844
PASS: prediction of activity spectra for biologically active substances
Lagunin, A. A., Stepanchikova, A. V., Filimonov, D. A., & Poroikov, V. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.8.747 · Cited by 1,164
Self-citationDictionary of Natural Products
(1995) · Springer eBooks · doi:10.1007/978-1-4899-3316-4 · Cited by 730
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 717
Meyler's Side Effects of Drugs
Breckenridge, A. (1976) · BMJ · doi:10.1136/bmj.2.6030.307 · Cited by 692
Macrolide antibiotics. Chemistry, biology, and practice
Nagel, A. A. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740930 · Cited by 476
Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries
Ertl, P., Roggo, S. P., & Schuffenhauer, A. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700286x · Cited by 395
Current Status of Herbal Drugs in India: An Overview
Vaidya, A. D. B., & Devasagayam, T. P. A. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2007001 · Cited by 299
Drugs of natural origin : a textbook of pharmacognosy
Samuelsson, G. (1999) · Medical Entomology and Zoology · Cited by 286
St John's wort: Prozac from the plant kingdom
Carlo, G. D., Borrelli, F., Ernst, E., & Izzo, A. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01716-8 · Cited by 279
Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
Morphy, R., & Ranković, Z. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315594 · Cited by 262
Poroikov, V., Filimonov, D. A., Borodina, Y. V., Lagunin, A. A., & Kos, A. J. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000383k · Cited by 254
Self-citationPASS Biological Activity Spectrum Predictions in the Enhanced Open NCI Database Browser
Poroikov, V., Filimonov, D. A., Ihlenfeldt, W., Gloriozova, T. A., Lagunin, A. A., Borodina, Y. V., Stepanchikova, A. V., & Nicklaus, M. C. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci020048r · Cited by 240
Self-citationPASS-assisted exploration of new therapeutic potential of natural products
Goel, R. K., Singh, D., Lagunin, A. A., & Poroikov, V. (2010) · Medicinal Chemistry Research · doi:10.1007/s00044-010-9398-y · Cited by 214
Self-citationFilimonov, D. A., Poroikov, V., Borodina, Y. V., & Gloriozova, T. A. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980335o · Cited by 198
Self-citationBiological spectra analysis: Linking biological activity profiles to molecular structure
Fliri, A. F. J., Loging, W., Thadeio, P. F., & Volkmann, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407790101 · Cited by 189
Geronikaki, A. A., Lagunin, A. A., Hadjipavlou‐Litina, D., Eleftheriou, P. T., Filimonov, D. A., Poroikov, V., Alam, I., & Saxena, A. K. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701496h · Cited by 177
Self-citationVirtual screening for the discovery of bioactive natural products
Rollinger, J. M., Stuppner, H., & Langer, T. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8117-2_6 · Cited by 168
Giorgio, C. D., Delmas, F., Ollivier, É., Élias, R., Balansard, G., & Timon-David, P. (2004) · Experimental Parasitology · doi:10.1016/j.exppara.2004.04.002 · Cited by 160
Where is the hope for drug discovery? Let history tell the future
De, K., Li, X., & Zhang, H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.002 · Cited by 158
Discriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS)
Anzali, S., Barnickel, G., Cezanne, B., Krug, M., Filimonov, D. A., & Poroikov, V. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0010670 · Cited by 146
Self-citationCyclobutane-Containing Alkaloids: Origin, Synthesis, and Biological Activities
Sergeiko, A., Poroikov, V., Hanus, L. O., & Dembitsky, V. M. (2008) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104500802010026 · Cited by 143
Self-citationRollinger, J. M., Schuster, D., Danzl, B., Schwaiger, S., Markt, P., Schmidtke, M., Gertsch, J., Raduner, S., Wolber, G., Langer, T., et al. (2008) · Planta Medica · doi:10.1055/s-0028-1088397 · Cited by 141
Kostrubsky, V. E. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg217 · Cited by 132
Phytochemistry and pharmacognosy
Phillipson, J. D. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.06.028 · Cited by 131
How to acquire new biological activities in old compounds by computer prediction
Poroikov, V., & Filimonov, D. A. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1023836829456 · Cited by 100
Self-citationEhrman, T. M., Barlow, D. J., & Hylands, P. J. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600288m · Cited by 94
Strategies for Efficient Lead Structure Discovery from Natural Products
Rollinger, J. M., Langer, T., & Stuppner, H. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777442075 · Cited by 93
Spectral mapping, a technique for classifying biological activity profiles of chemical compounds.
Pj, L. (1976) · PubMed · Cited by 89
Essential oil composition of Hypericum L. species from Southeastern Serbia and their chemotaxonomy
Šmelcerović, A., Spiteller, M., Ligon, A. P., Šmelcerović, Ž., & Raabe, N. (2006) · Biochemical Systematics and Ecology · doi:10.1016/j.bse.2006.09.012 · Cited by 81
Benzothiazoles: A new profile of biological activities
Siddiqui, N., Khan, S. A., & Rana, A. (2007) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.32100 · Cited by 80
Prediction of Biological Activity Spectra via The Internet
Sadym, A., Lagunin, A. A., Filimonov, D. A., & Poroikov, V. (2003) · SAR and QSAR in environmental research · doi:10.1080/10629360310001623935 · Cited by 72
Self-citationEssential oil composition and variability of Hypericum perforatum L. growing in Lithuania
Radušienė, J., Judžentienė, A., & Bernotienë, G. (2004) · Biochemical Systematics and Ecology · doi:10.1016/j.bse.2004.06.010 · Cited by 62
Delmas, F., Giorgio, C. D., Robin, M., Azas, N., Gasquet, M., Detang, C., Costa, M., Timon-David, P., & Galy, J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2588-2594.2002 · Cited by 54
Polyketide biosynthesis: understanding and exploiting modularity
Weissman, K. J. (2004) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2004.1470 · Cited by 52
Giorgio, C. D., Delmas, F., Filloux, N., Robin, M., Seferian, L., Azas, N., Gasquet, M., Costa, M., Timon-David, P., & Galy, J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.174-180.2003 · Cited by 49
Accessing target information by virtual parallel screening—The impact on natural product research
Rollinger, J. M. (2008) · Phytochemistry Letters · doi:10.1016/j.phytol.2008.12.002 · Cited by 45
Structure-activity relationship oriented languages for chemical structure representation
Avidon, V. V., Pomerantsev, I. A., Golender, V. E., & Rozenblit, A. B. (1982) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00036a006 · Cited by 39
Cheminformatics based selection and cytotoxic effects of herbal extracts
Sardari, S., Shokrgozar, M. A., & Ghavami, G. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.07.011 · Cited by 38
PASS: Prediction of Biological Activity Spectra for Substances
Poroikov, V., & Filimonov, D. (2005) · CRC Press eBooks · doi:10.1201/9780849350351-15 · Cited by 38
Self-citationLogical and combinatorial algorithms for drug design
Golender, V. E., & Rozenblit, A. B. (1983) · Andalas University Repository (Andalas University) · Cited by 37
ExPlain™: finding upstream drug targets in disease gene regulatory networks
Kel, A. E., Voss, N., Valeev, T., Stegmaier, P., Kel-Margoulis, O. V., & Wingender, E. (2008) · SAR and QSAR in environmental research · doi:10.1080/10629360802083806 · Cited by 33
Zotchev, S. B., Stepanchikova, A. V., Sergeyko, A. P., Sobolev, B. N., Filimonov, D. A., & Poroikov, V. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051035i · Cited by 32
Self-citationQuinazolines revisited: search for novel anxiolytic and GABAergic agents
Goel, R. K., Kumar, V., & Mahajan, M. P. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.023 · Cited by 31
Acetylenic Aquatic Anticancer Agents and Related Compounds
Dembitsky, V. M., Levitsky, D. O., Gloriozova, T. A., & Poroikov, V. (2006) · Natural Product Communications · doi:10.1177/1934578x0600100914 · Cited by 24
Self-citationHypericum Perforatum - St. John's Wort Chemical, Pharmacological and Clinical Aspects
ERDELMEIER, C. A. J., Koch, E., & Hoerr, R. (2000) · Studies in natural products chemistry · doi:10.1016/s1572-5995(00)80037-x · Cited by 22
Prediction of biological activity profiles of cyanobacterial secondary metabolites
Devillers, J., Doré, J., Guyot, M., Poroikov, V., Gloriozova, T. A., Lagunin, A. A., & Filimonov, D. A. (2007) · SAR and QSAR in environmental research · doi:10.1080/10629360701698704 · Cited by 21
Self-citationA Study of Russian Phytomedicine and Commonly Used Herbal Remedies
Domarew, C., Holt, R. R., & Goodman-Snitkoff, G. (2002) · Journal of Herbal Pharmacotherapy · doi:10.1080/j157v02n04_04 · Cited by 18
The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow
Pors, K., Goldberg, F. W., Leamon, C. P., Rigby, A. C., Snyder, S. A., & Falconer, R. A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.004 · Cited by 15
In silicomethod for identification of promising anticancer drug targets
Koborova, O., Filimonov, D. A., Zakharov, A. V., Lagunin, A. A., Ivanov, S. M., Kel, A. E., & Poroikov, V. (2009) · SAR and QSAR in environmental research · doi:10.1080/10629360903438628 · Cited by 14
Self-citationActivity spectra of Bacillus Thuringiensis δ-endotoxins against eight insect cell lines
Gringorten, J. L., Sohi, S. S., & Masson, L. (1999) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-999-0075-8 · Cited by 11
Dolzhenko, A. V., Васильевна, К. Н., Kozminykh, V. O., Vasilyuk, M. V., Котегов, В. П., Новоселова, Г. Н., Syropyatov, B. Y., & Vakhrin, M. I. (2003) · Pharmaceutical Chemistry Journal · doi:10.1023/a:1024542815933 · Cited by 9
Spectrum of biological activity of interferons.
Battistini, A., Affabris, E., Fiorucci, G., Coccia, E. M., Romeo, G., Marziali, G., & Rossi, G. B. (1990) · PubMed · Cited by 8
Synthesis and anti-inflammatory activity of 1-acylaminoalkyl-3,4-dialkoxybenzene derivatives
Labanauskas, L., Brukstus, A., Udrenaite, É. B., Bucinskaite, V., Susvilo, I., & Urbelis, G. (2005) · Il Farmaco · doi:10.1016/j.farmac.2004.12.003 · Cited by 7
Avidon, V. V. (1974) · Pharmaceutical Chemistry Journal · doi:10.1007/bf00757886 · Cited by 6
Avidon, V. V., Arolovich, V. S., Blinova, V. G., & Freidina, A. M. (1983) · Pharmaceutical Chemistry Journal · doi:10.1007/bf00765247 · Cited by 3
Avidon, V. V., Arolovich, V. S., Kozlova, S. P., & Piruzyan, L. A. (1978) · Pharmaceutical Chemistry Journal · doi:10.1007/bf00779056 · Cited by 1
Cited by
Sorted by citations
Filimonov, D. A., Lagunin, A. A., Gloriozova, T. A., Rudik, A. V., Druzhilovskiy, D. S., Pogodin, P. V., & Poroikov, V. (2014) · Chemistry of Heterocyclic Compounds · doi:10.1007/s10593-014-1496-1 · Cited by 1,359
Self-citationCounting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Self-citationArtificial intelligence for natural product drug discovery
Mullowney, M. W., Duncan, K., Elsayed, S. S., Garg, N., van der Hooft, J. J. J., Martin, N. I., Meijer, D., Terlouw, B. R., Biermann, F., Blin, K., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00774-7 · Cited by 551
Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology
Gu, J., Gui, Y., Chen, L., Yuan, G., Lu, H., & Xu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062839 · Cited by 419
Metadata
- Authors
- Lagunin, A., Filimonov, D., & Poroikov, V.
- Affiliations
- Institute of Biomedical Chemistry (RU)
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-05-01
- Volume
- 16
- Issue
- 15
- Pages
- 1703-1717
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2027991790
- Cited by
- 179
- References
- 60
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 11 · 2020: 7 · 2019: 12 · 2018: 9 · 2017: 13 · 2016: 11 · 2015: 13 · 2014: 17 · 2013: 8 · 2012: 3
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Bioactive natural compounds
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- PASS software, bioactivity prediction, marine sponge alkaloids, lupane triterpenoids, macrolides, drug-drug interactions, synergistic and antagonistic effects, drug discovery, structure-activity relationship
- MeSH terms
- Alkaloids, Animals, Biological Products, Drug Interactions, Porifera, Software, Structure-Activity Relationship, Triterpenes, Hypericum, Plant Preparations, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
